Menarini was founded in 1886.In 1915 its headquarters were established in Florence.
1
1964 Opening of Laboratorios Menarini in Barcelona, Spain. This was the beginning of Menarini's internationalisation.
1978 Menarini's Research & Development
was set up at the same time patent legislation for pharmaceutical products was introduced.
1992 With the acquisition of Berlin-Chemie, Menarini entered the markets of Central and Eastern Europe.
Milestones
2
2011 Acquisition of Invida Group, with companiescovering 13 Asia-Pacific countries, nownamed Menarini Asia-Pacific.
2003 Inauguration of Menarini Biotech, anitalian biotechnological company thatcan research, develop and manufacturebiotech pharmaceutical products from the laboratory phase up to production for themarket.
2016 Founding of Vaxynethic, a joint venture company dedicated to the research of innovative technologies for vaccines manufacturing.
Acquisition of CellSearch, a U.S.Company developing advanced technologies for cancer diagnostics.
2013 Acquisition of Silicon Biosystems,
a technology start-up for diagnostics from
liquid biopsies.
Source: IQVIA (Retail Market)
3
MENARINI IN THE
35th 13th
Today Menarini is present in more than 100 countries
WORLD COMPANIES EUROPEAN COMPANIES
PLACE
MENARINI IN THE
PLACE
Please Note: 11th among the Big Five (France, Germany, Italy, Spain and UK)
113
794
1,306
1,869
2,627
1964 1978 1992 2000 2004 2008
4
2015
3,326
2016
3,527
2010
3,031
Consolidated turnover(Million euro)
Source: internal data
3,600
2017
Consolidated turnover (Year 2017)
Source: internal data
TURNOVER PER BUSINESS AREA
DOMESTIC/INTERNATIONAL TURNOVER
Other 1%
Pharmaceutical 93%
Diagnostics 6%
Italy 25%
Abroad 75%
5
Menarini in Europe
Sweden: Menarini Diagnostics presence
6
Menarini in the world
The Menarini Group is present with its affiliates, distributors and franchises
in 136 countries worldwide.
7
Asia-Pacific Region – Australia
• 2017 turnover over 350 Million Euro
• More than 3,000 employees
• Direct presence: Singapore (headquarters), China, India, Australia, South Korea, Taiwan, Thailand, the Philippines, Indonesia, Vietnam, New Zealand, Hong Kong and Malaysia.
8
9
*Corporations; 1 Lithuania, Latvia, Estonia2 Honduras, Nicaragua, El Salvador, Guatemala, Panama, Costa Rica
Menarini is leader in many Countries
RANK
Italy* 1Baltic States1 1Uzbekistan*° 1Moldova*° 1
Armenia° 1
Azerbaijan*° 1
Georgia*° 2
Central America 2 4
Bulgaria 4
Kazakhstan 4
Russia 5
Kyrgyzstan*° 5
Ukraine*°° 6
Poland 8
Belarus° 9
Greece 10
Romania 10
Bosnia & H.* 12
Spain 14
Czech* 14
Germany* 15
RANK
Turkey* 15Portugal* 16Croatia* 16Hungary 17
Slovakia* 17
Serbia 17
Luxembourg 19
Belgium* 20
Philippines* 21
Austria* 23
Dominican Rep* 26
Singapore* 26
Slovenia* 26
Ireland* 27
Lebanon* 27
Malaysia* 30
France* 31
Tunisia* 32
Thailand* 33
Switzerland* 36
UK* 37
(Year 2017)
Sources: IQVIA WRP Q4 2017 - ° Local IQVIA Dec 17 - °° PHARMASTAND Dec 17
2016
16,722
2015201020082004200019901964
16,265
12,89012,584
11,170
7,954
3,606
188
10
1994
5,225
Source: internal data
Number of employees
2017
17,029
Employees - % of graduates and technicians
1964 1990 2014
10%
72%91%
11
2017
16 production plantsIn 2017 these plants produced 583 million packs of pharmaceuticals products.
Italy
Pisa, Florence (2 centres),
L'Aquila, Lomagna (Lecco),
Casaletto Lodigiano (Lodi)
Germany Berlin (2 centres), Dresden
Spain Barcelona
Ireland Shannon
Russia Kaluga
Turkey Istanbul
Central America Guatemala City
Indonesia Jakarta
USA Philadelphia (Huntingdon Valley)*
12
* Diagnostic production
Research & Development Centres
13
1978 11 employees in Menarini R&D in Florence
2017 920 employees in Menarini R&D
PISA
FLORENCE
ROMEBARCELONA
BERLIN
BOLOGNA
SINGAPORE